A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation
Lucia Carratala-Castro,Willy Ssengooba,Alex Kay,Sozinho Acácio,Joanna Ehrlich,Andrew R DiNardo,Nosisa Shiba,Joachim K Nsubuga,Shilzia Munguambe,Belén Saavedra-Cervera,Patricia Manjate,Durbbin Mulengwa,Busizwe Sibandze,Mangaliso Ziyane,George Kasule,Edson Mambuque,Moorine Penninah Sekadde,Eric Wobudeya,Moses L Joloba,Jan Heyckendorf,Christoph Lange,Sabine Hermans,Anna Mandalakas,Alberto L. García-Basteiro,Elisa Lopez-Varela,Sergi Sanz,Makhosazana Dlamini,Gcinile Dlamini,Nomathemba Dlamini,Nkulungwane Mthethwa,Nokwanda Kota,Mbongeni Dube,Nontobeko Maphalala,Babongile Nkala,Faith Dlamini,Fortunate Shabalala,Sindisiwe Dlamini,Gugu Maphalala,Lindiwe Dlamini,Sisi Dube,Lee Joao Fonseca,Nércio Machele,Miguel Cumbe,Agostinho Lima,Katia Magul,Gustavo Tembe,Benilde Violeta Mudumane,Farida Cebola,Jorcelina Rungo,Alberto Bila Junior,Neide Gomes,Patricia Mwachan,Maria Nassolo,Sujan Katuwal,Matthew Ang,Anca Vasiliu,Rojelio Mejía,Jason Bacha,Debrah Vambe,Abigail Seeger,Irina Kontsevaya,Collins Musia,Lilian Komba,Lwijisyo Minga,Lumumba Mwita,Mtafya Bariki,Nyanda Elias Ntinginya,on behalf of Stool4TB Global Partnership
DOI: https://doi.org/10.1186/s12879-023-08708-9
IF: 3.7
2024-02-22
BMC Infectious Diseases
Abstract:Tuberculosis (TB) is a major cause of mortality worldwide. Children and people living with HIV (PLHIV) have an increased risk of mortality, particularly in the absence of rapid diagnosis. The main challenges of diagnosing TB in these populations are due to the unspecific and paucibacillary disease presentation and the difficulty of obtaining respiratory samples. Thus, novel diagnostic strategies, based on non-respiratory specimens could improve clinical decision making and TB outcomes in high burden TB settings. We propose a multi-country, prospective diagnostic evaluation study with a nested longitudinal cohort evaluation to assess the performance of a new stool-based qPCR, developed by researchers at Baylor College of Medicine (Houston, Texas, USA) for TB bacteriological confirmation with promising results in pilot studies.
infectious diseases